Deal Watch: Bristol Places Early Wager On Padlock's Autoimmune Potential
Executive Summary
Regeneron and Bayer look to build on their past success collaborating in ophthalmology by partnering to develop an Eylea successor. Sun Pharma builds its portfolio with 13 products from Novartis.